Literature DB >> 27103715

Draft Genome Sequence of an Atypical Strain of Streptococcus pneumoniae Serotype 19A Isolated from Cerebrospinal Fluid.

Antonio Ali Perez-Maya1, Rosa Maria Hinojosa-Robles2, Jose Ramon Barcenas-Walls3, Augusto Rojas-Martinez4, Hugo Alberto Barrera-Saldaña1, Rocio Ortiz-Lopez5.   

Abstract

We present here the draft genome sequence of ITALIC! Streptococcus pneumoniaestrain MTY32702340SN814 isolated in Monterrey, Mexico, from a girl with bacterial meningitis. The strain belongs to the atypical and multidrug-resistant serogroup 19A. This is the first report in the literature of sequence type 3936 (ST3936) in ITALIC! S. pneumoniaeserotype 19A.
Copyright © 2016 Perez-Maya et al.

Entities:  

Year:  2016        PMID: 27103715      PMCID: PMC4841130          DOI: 10.1128/genomeA.00277-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Streptococcus pneumoniae is associated with significant morbidity and mortality, mainly in children and the elderly (1). The introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in the United States and other Western countries has significantly reduced the incidence of invasive pneumococcal disease (IPD) by the seven vaccine strains (2, 3). However, the increasing global emergence and rapid spread of serotypes not included in PCV7, as well as the rise in the number of cases of invasive infections caused by these serotypes, are a serious concern (3, 4). Particularly, serotype 19A sequence type 320 (ST320) is currently considered an emerging strain associated with IPD and multidrug resistance (MDR) (5–8). S. pneumoniae MTY32702340SN814 (ST3936, serotype 19A) is a multidrug-resistant strain isolated from a cerebrospinal fluid sample from a 12-year-old girl in 2014 at the Hospital Regional Materno Infantil in Northeast Mexico. This patient suffered acute meningitis and died on the day of admission. Strain MTY32702340SN814 was resistant to penicillin, trimethoprim-sulfamethoxazole, and tetracycline (9). Additionally, the allelic profile (ST3936) of our isolate has been compared with those in the reference multilocus sequence typing (MLST) database (http://spneumoniae.mlst.net/), and only three pneumococcal isolates had a profile identical to that of our strain. The above-mentioned three strains (from serotype 19A-ST3936) were from U.S. patients who had developed pneumonia. Furthermore, we searched for isolates in our region that had allelic profiles similar to ours, with at least 6/7 matches, and we found single-locus variants from ST230, which differs in xpt (xanthine phosphoribosyltransferase), and ST4511, which differs in ddl (d-alanine–d-alanine ligase), both recovered from patients with invasive disease in the United States. This occurrence may represent a new clonal group and therefore, it will be necessary to continue molecular surveillance to monitor the ability of serotype 19A-ST3936 to spread within the region. The genome was sequenced using the Illumina MiSeq platform (250-bp paired-end reads). A total of 2,147,688 reads were obtained, providing about 57-fold genome coverage. De novo assemblies were performed using the SPAdes genome assembler version 3.5.0 software (10). The unclosed draft genome of MTY32702340SN814 was assembled into 236 contigs (≥500 bp), with a total length of 2,191,102 bp and a G+C content of 40.9%. The genome assembly was annotated using the NCBI Prokaryotic Genome Annotation Pipeline (11). Additionally, a total of 2,403 genes were predicted, which included 2,073 coding sequences (CDSs), 5 rRNAs (three copies of 5S, one copy of 16S, and one copy of 23S rRNA genes), 48 tRNAs, and 3 noncoding RNAs (ncRNAs).

Nucleotide sequence accession numbers.

This whole-genome shotgun project has been deposited at DDBJ/ENA/GenBank under the accession no. LSSU00000000. The version described in this paper is version LSSU01000000.
  10 in total

1.  SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing.

Authors:  Anton Bankevich; Sergey Nurk; Dmitry Antipov; Alexey A Gurevich; Mikhail Dvorkin; Alexander S Kulikov; Valery M Lesin; Sergey I Nikolenko; Son Pham; Andrey D Prjibelski; Alexey V Pyshkin; Alexander V Sirotkin; Nikolay Vyahhi; Glenn Tesler; Max A Alekseyev; Pavel A Pevzner
Journal:  J Comput Biol       Date:  2012-04-16       Impact factor: 1.479

2.  Toward an online repository of Standard Operating Procedures (SOPs) for (meta)genomic annotation.

Authors:  Samuel V Angiuoli; Aaron Gussman; William Klimke; Guy Cochrane; Dawn Field; George Garrity; Chinnappa D Kodira; Nikos Kyrpides; Ramana Madupu; Victor Markowitz; Tatiana Tatusova; Nick Thomson; Owen White
Journal:  OMICS       Date:  2008-06

3.  Clonal replacement among 19A Streptococcus pneumoniae in Massachusetts, prior to 13 valent conjugate vaccination.

Authors:  W P Hanage; C J Bishop; G M Lee; M Lipsitch; A Stevenson; S L Rifas-Shiman; S I Pelton; S S Huang; J A Finkelstein
Journal:  Vaccine       Date:  2011-09-29       Impact factor: 3.641

4.  Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children.

Authors:  Sheldon L Kaplan; William J Barson; Philana L Lin; Stephanie H Stovall; John S Bradley; Tina Q Tan; Jill A Hoffman; Laurence B Givner; Edward O Mason
Journal:  Pediatrics       Date:  2010-02-22       Impact factor: 7.124

Review 5.  Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines.

Authors:  Tina Q Tan
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

6.  Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.

Authors:  Heather E Hsu; Kathleen A Shutt; Matthew R Moore; Bernard W Beall; Nancy M Bennett; Allen S Craig; Monica M Farley; James H Jorgensen; Catherine A Lexau; Susan Petit; Arthur Reingold; William Schaffner; Ann Thomas; Cynthia G Whitney; Lee H Harrison
Journal:  N Engl J Med       Date:  2009-01-15       Impact factor: 91.245

7.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

8.  Increase of pneumococcal serotype 19A in Italy is due to expansion of the piliated clone ST416/CC199.

Authors:  Maria Del Grosso; Romina Camilli; Fabio D'Ambrosio; Giulia Petrucci; Sara Melchiorre; Monica Moschioni; Giovanni Gherardi; Annalisa Pantosti
Journal:  J Med Microbiol       Date:  2013-05-30       Impact factor: 2.472

9.  Characterization of Streptococcus pneumoniae invasive serotype 19A isolates recovered in Colombia.

Authors:  Viviana Ramos; Eliana L Parra; Carolina Duarte; Jaime Moreno
Journal:  Vaccine       Date:  2013-12-25       Impact factor: 3.641

10.  Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae.

Authors:  Dylan R Pillai; Dea Shahinas; Alla Buzina; Remy A Pollock; Rachel Lau; Krishna Khairnar; Andrew Wong; David J Farrell; Karen Green; Allison McGeer; Donald E Low
Journal:  BMC Genomics       Date:  2009-12-30       Impact factor: 3.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.